APA (7th ed.) Citation

YL, T., SB, T., S, H., S, N., SR, T., R, M., . . . MA, P. (2026). Silencing of human HTT by targeted CRISPR/dCas9-mediated epigenetic editing. Journal of Huntington's disease, 15(3), 399. https://doi.org/10.1177/18796397251415368

Chicago Style (17th ed.) Citation

YL, Tay, et al. "Silencing of Human HTT by Targeted CRISPR/dCas9-mediated Epigenetic Editing." Journal of Huntington's Disease 15, no. 3 (2026): 399. https://doi.org/10.1177/18796397251415368.

MLA (9th ed.) Citation

YL, Tay, et al. "Silencing of Human HTT by Targeted CRISPR/dCas9-mediated Epigenetic Editing." Journal of Huntington's Disease, vol. 15, no. 3, 2026, p. 399, https://doi.org/10.1177/18796397251415368.